Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China
- 133 Downloads
The optimal extent of lymph node (LN) dissection remains controversial in adenocarcinoma of the esophagogastric junction (AEG), especially in Siewert types II and III. The aim of this study was to analyze clinicopathological characteristics of patients with Siewert type II and III AEGs to clarify whether pyloric (no. 5 and no.6) lymphadenectomy is essential in these patients.
A retrospective analysis was performed in the Third Affiliated Hospital of Soochow University from September 2008 to December 2012, and clinicopathological characteristics on all patients with Siewert type II and III AEGs, who underwent curative total gastrectomy with lymphadenectomy were collected. The index of estimated benefit from lymph node dissection (IEBLD) was used to evaluate the efficacy of lymph node dissection of no. 5 and no. 6. Both clinicopathological characteristics and IEBLDs were set as the standards in the assessment of the value of pyloric lymph nodes dissection.
A total of 216 patients with AEG (Siewert type II: 141, Siewert type III: 75) were included into the study. Type III AEG had a larger tumor size and relatively advanced T stage compared to Type II AEG. The 5-year overall survival (OS) rates in type II and type III AEGs were almost similar (type II 50.4% vs. type III 46.7%, p = 0.782). There was a very low incidence of pyloric lymph nodes metastases in type II AEG (no. 5 is 1.4% and no. 6 is 0.7%). Hence, the IEBLDs of no. 5 and no. 6 lymph node were negligible regardless of the T stage and tumor differentiation. In type III AEG, metastasis rates of no. 5 and no. 6 lymph node were 9.3 and 5.3%, respectively. The IEBLDs of no. 5 and no. 6 lymph node were 2.7 and 1.3, respectively.
Based on the IEBLDs of pyloric lymph nodes, dissection of no. 5 and no. 6 lymph nodes were worthwhile for Siewert type III AEG but not essential for Siewert type II AEG.
KeywordsAdenocarcinoma of the esophagogastric junction Lymphadenectomy Siewert type II Siewert type III
Huihua Cao and Marie Ooi wrote the manuscript and analyzed clinicopathological data. Zhan Yu, Qing Wang and Zhong Li carried out the follow-ups and collected the clinicopathological data of patients. Yugang Wu and Qicheng Lu assisted Huihua Cao and Marie Ooi to complete the work and Yugang Wu funded the study.
The present study was supported by the Changzhou Municipal Scientific Research grant (grant no. CE20125020).
Compliance with Ethical Standards
The authors have no financial conflict of interest.
- 1.Goto H, Tokunaga M, Miki Y, Makuuchi R, Sugisawa N, Tanizawa Y, Bando E, Kawamura T, Niihara M, Tsubosa Y, Terashima M. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients. Gastric cancer 2015;18:375–381.CrossRefGoogle Scholar
- 2.Xiao JW, Liu ZL, Ye PC, Luo YJ, Fu ZM, Zou Q, Wei SJ. Clinical comparison of antrum-preserving double tract reconstruction vs roux-en-Y reconstruction after gastrectomy for Siewert types II and III adenocarcinoma of the esophagogastric junction. World journal of gastroenterology 2015;21:9999–10007.CrossRefGoogle Scholar
- 5.Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution. Journal of the American College of Surgeons 1999;189:594–601.CrossRefGoogle Scholar
- 9.Ilhan E, Ureyen O, Meral UM. Ongoing problems concerning 7(th) TNM staging system and proposals for 8(th) TNM staging system of gastric cancer. Przeglad gastroenterologiczny 2016;11:223–225.Google Scholar
- 10.Hasegawa S, Yoshikawa T, Cho H, Tsuburaya A, Kobayashi O. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World journal of surgery 2009;33:95–103.CrossRefGoogle Scholar
- 11.Chen XZ, Zhang WH, Hu JK. Lymph node metastasis and lymphadenectomy of resectable adenocarcinoma of the esophagogastric junction. Chinese journal of cancer research 2014;26:237–242.Google Scholar
- 13.Aday U, Gundes E, Ciyiltepe H, Cetin DA, Gulmez S, Senger AS, Deger KC, Duman M. Examination of anastomotic leak with aqueous contrast swallow after total gastrectomy: should it be carried out routinely? Contemporary oncology 2017;21:224–227.Google Scholar
- 14.Huh YJ, Lee HJ, Oh SY, Lee KG, Yang JY, Ahn HS, Suh YS, Kong SH, Lee KU, Yang HK. Clinical outcome of modified laparoscopy-assisted proximal gastrectomy compared to conventional proximal gastrectomy or total gastrectomy for upper-third early gastric cancer with special references to postoperative reflux esophagitis. Journal of gastric cancer 2015;15:191–200.CrossRefGoogle Scholar
- 17.Pu YW, Gong W, Wu YY, Chen Q, He TF, Xing CG. Proximal gastrectomy versus total gastrectomy for proximal gastric carcinoma. A meta-analysis on postoperative complications, 5-year survival, and recurrence rate. Saudi medical journal 2013;34:1223–1228.Google Scholar
- 19.Aratani K, Komatsu S, Ichikawa D, et al. Overexpression of EGFR as an independent prognostic factor in adenocarcinoma of the esophagogastric junction. Anticancer Res 2017;37:3129–3135.Google Scholar
- 22.Fujitani K, Miyashiro I, Mikata S, Tamura S, Imamura H, Hara J, Kurokawa Y, Fujita J, Nishikawa K, Kimura Y, Takiguchi S, Mori M, Doki Y. Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study. Gastric Cancer 2013;16:301–308.CrossRefGoogle Scholar
- 24.Shen KR, Cassivi SD, Deschamps C, Allen MS, Nichols FC, Harmsen WS, Pairolero PC. Surgical treatment of tumors of the proximal stomach with involvement of the distal esophagus: a 26-year experience with Siewert type III tumors. The Journal of Thoracic and Cardiovascular Surgery 2006;132:755–762.CrossRefGoogle Scholar
- 25.Mocellin S, McCulloch P, Kazi H, Gama-Rodrigues JJ, Yuan Y, Nitti D. Extent of lymph node dissection for adenocarcinoma of the stomach. The Cochrane Database of Systematic Reviews 2015;Cd001964.Google Scholar